Tau as a diagnostic instrument in clinical trials to predict amyloid in Alzheimer's disease

INTRODUCTION: Alzheimer's disease (AD) is characterized by the presence of both amyloid and tau pathology. In vivo diagnosis can be made with amyloid and tau positron emission tomography (PET) imaging. Emergent evidence supports that amyloid and tau accumulation are associated and that amyloid...

Descripción completa

Detalles Bibliográficos
Autores principales: Shcherbinin, Sergey, Morris, Amanda, Higgins, Ixavier A., Tunali, Ilke, Lu, Ming, Deveau, Carmen, Southekal, Sudeepti, Kotari, Vikas, Evans, Cynthia D., Arora, Anupa K., Collins, Emily C., Pontecorvo, Michael, Mintun, Mark A., Sims, John R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432878/
https://www.ncbi.nlm.nih.gov/pubmed/37600216
http://dx.doi.org/10.1002/trc2.12415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432878/
https://www.ncbi.nlm.nih.gov/pubmed/37600216
http://dx.doi.org/10.1002/trc2.12415

Ejemplares similares